Analyst Ratings for AN2 Therapeutics (ANTX)

ANTX Rating Summary

  |   Expand Research on ANTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/18/2024 TD Cowen Ritu Baral Downgrade Hold
(Buy)		 N/A
(N/A)		 1.00
(2.85)		 185% Details
8/9/2024 Evercore ISI Liisa Bayko Downgrade Underperform
(In Line)		 2.00
(N/A)		 2.64
(2.85)		 7.95% Details